Haptoglobin in Athletes: The Hemolysis Detection Marker
Table of Contents
Introduction
Some of my patients may have heard of the protein haptoglobin, but it remains relatively unfamiliar—and even when recognized, it is often misunderstood. The topic of haptoglobin in athletes is somewhat more familiar among endurance athletes, where exercise-induced hemolysis can reduce haptoglobin levels.
In clinical practice, haptoglobin is most commonly encountered in hematological evaluations, such as when assessing hemolysis or other blood disorders. However, it is also encountered in athletic populations, particularly among endurance athletes—although in this context, it is usually of limited clinical relevance.
For distance runners in particular, haptoglobin occupies a unique diagnostic position. It can simultaneously be an important signal that the body’s red blood cells are taking mechanical damage with every footstrike, and a red flag requiring urgent investigation if the clinical picture does not fit the expected athletic pattern. Understanding the difference is not an academic exercise — it is the kind of distinction that separates appropriate clinical reassurance from a missed diagnosis.
In this article, I explain what haptoglobin actually measures, why runners are particularly prone to low or even absent levels, and when a low result should prompt further investigation rather than reassurance.
Haptoglobin in Athletes: What It Does and Why It Matters
Haptoglobin is a glycoprotein produced primarily by the liver whose function is to bind free hemoglobin released when red blood cells rupture [10]. Under normal conditions, red blood cells live approximately 120 days before being cleared by the spleen and liver. When cells are destroyed prematurely — through mechanical force, immune attack, or disease — hemoglobin spills into plasma. Free hemoglobin is toxic: it causes oxidative damage to vessel walls, depletes nitric oxide, and can damage the kidneys directly if excreted through the glomerulus.
Haptoglobin intercepts this free hemoglobin, binding it with high affinity to form a stable complex that is cleared via the CD163 scavenger receptor on macrophages in the liver and spleen [10]. In the process, iron is conserved and kidney damage is prevented. This is why haptoglobin is consumed during hemolysis: the more hemoglobin released, the more haptoglobin is bound and removed from circulation. The plasma concentration of haptoglobin is a limiting factor — during accelerated hemolysis, its depletion can allow excess hemoglobin to reach the kidney [10]. When hemolysis is substantial, haptoglobin levels fall — sometimes to zero.
The clinical value of haptoglobin as a hemolysis marker is well-established. A haptoglobin level below 25 mg/dL has been reported to identify hemolytic disease with a sensitivity of 83% and specificity of 96%, with a corresponding predictive value of approximately 87%[7]. Unlike lactate dehydrogenase (LDH), which rises from multiple tissue sources including muscle, or indirect bilirubin, which depends on hepatic clearance capacity, a suppressed haptoglobin provides a relatively clean signal attributable to erythrocyte destruction and hemoglobin release — though as with any single marker, it is most informative when interpreted alongside the full hemolytic panel.
In clinical practice, I typically use haptoglobin as part of second-line investigations for anemia. By this stage, some form of anemia has usually already been identified, and the aim is to rule out underlying hemolysis. It is not something I routinely include in first-line testing and is typically absent from standard iron panels. However, in unclear cases requiring further evaluation, I will often order it alongside other markers to help exclude hemolysis.
Why Runners Consistently Show Low Haptoglobin
The most thoroughly documented cause of low haptoglobin in otherwise healthy athletes is footstrike hemolysis — the mechanical destruction of red blood cells in the capillaries of the plantar foot during running. With each footstrike, compressive forces are transmitted through the foot’s microcirculation, generating sufficient mechanical stress to rupture erythrocytes.
A pivotal study comparing 10 male triathletes performing one hour of running versus one hour of cycling at equivalent oxygen uptake confirmed that footstrike is the dominant contributor to exercise-induced hemolysis. Plasma free hemoglobin increased fourfold more after running than cycling, and haptoglobin declined significantly after running while remaining unchanged after cycling at any measured timepoint[3]. Exercise-induced hemolysis is recognized as multifactorial — involving shear stress, vasoconstriction, osmotic stress, oxidative damage, and metabolic changes in addition to direct mechanical plantar impact — but the substantially greater hemolytic response during running compared to matched cycling suggests ground contact forces as the primary driver[2][3].
A 2024 scoping review of nine studies encompassing 267 marathon and ultramarathon runners quantified the typical magnitude of this response: haptoglobin levels decreased by 21% between pre- and post-race measurements, while reticulocyte count increased by 16%, consistent with compensatory erythropoiesis [1]. Crucially, hemoglobin concentration and hematocrit did not change notably in most subjects, reflecting the self-limiting nature of exercise-induced hemolysis in well-trained athletes.
For longer and more extreme races, the suppression deepens. In a study of 18 male athletes completing a 60 km ultramarathon, haptoglobin fell by approximately 50% post-race, despite no clinically significant change in hemoglobin, hematocrit, or red blood cell count[4]. A 2025 study of athletes completing a 230 km non-stop ultramarathon similarly documented significantly reduced post-race haptoglobin levels without meaningful changes in RBC count or hemoglobin concentration[9]. This pattern—characterized by reduced haptoglobin levels with relatively stable hemoglobin values—has been observed across multiple studies, although the magnitude of suppression and the rate of recovery vary depending on training status, race distance, and individual factors[2].
At the same time, it is important to remember that reduced haptoglobin and exercise-induced hemolysis in endurance athletes rarely have direct clinical significance. In most cases, this process does not lead to clinically meaningful anemia, nor does it typically cause symptoms. It is often more of a laboratory finding than a clinically relevant problem—particularly when haptoglobin is measured shortly after a prolonged athletic effort.
That said, in some cases, endurance athletes may develop anemia, and prolonged or extreme exertion—such as long-distance marches—can occasionally lead to clinically significant reductions in hemoglobin. However, this appears to be relatively uncommon in practice.
In this sense, low haptoglobin in endurance athletes is often best understood as an incidental or context-dependent finding, or something observed in research settings examining exercise-related anemia, rather than a marker with clear clinical consequences in most individuals.
Recovery Timeline: What to Expect
The kinetics of haptoglobin recovery after acute exercise-induced depletion are relevant to clinical test timing. Recovery depends on both the rate of hepatic re-synthesis and the cessation of ongoing red cell destruction, and evidence from multiple studies compiled in a 2019 narrative review suggests that recovery timelines vary considerably by exercise load and individual factors [2].
In one representative marathon cohort, plasma haptoglobin values in 23 male runners decreased from 1.20 ± 0.15 g/L before the race to approximately 0.75 g/L immediately after, remained depressed at 12 hours (0.85 g/L), and returned to pre-race baseline at 72 hours post-completion [2]. In a separate marathon cohort, both plasma free hemoglobin and haptoglobin returned to baseline within 24 hours [2]. Following a maximal 5-km effort in 11 elite middle-distance runners, haptoglobin decreased approximately 4.7-fold at race end — a more dramatic acute suppression than typically seen after trained marathon performance, reflecting the high intensity relative to habitual exercise load [2].
The practical implication is that blood tests collected within 24–72 hours of a hard running session can show meaningfully suppressed haptoglobin. This is not necessarily pathological — it can be the expected physiological response to acute mechanical hemolysis. For a broader overview of how exercise timing affects multiple laboratory values simultaneously, see the post-marathon blood work article on this site. To obtain a resting baseline that reflects actual iron metabolism status rather than acute exercise response, testing should ideally allow sufficient recovery from the most recent hard session; the appropriate interval varies by exercise intensity and individual response, but erring toward 72 hours or beyond is generally prudent.
In practice, haptoglobin is not a routine test in athletes and, in itself, has little clinical significance in this population. This peculiarity in athletes is worth keeping in mind if haptoglobin is measured for other reasons, but exercise alone is not an indication for testing.
From a performance perspective, haptoglobin has no meaningful role—it does not affect athletic performance, nor is there anything that needs to be corrected, as reduced levels are a natural consequence of training. Only if there is suspicion of an underlying pathological cause—particularly in cases of elevated or persistently abnormal values—should further evaluation be considered.
Haptoglobin and Iron Deficiency: The Cumulative Connection
A single hemolytic episode — even one that drives haptoglobin to near zero temporarily — is unlikely to cause clinically significant iron loss. This is because haptoglobin captures free hemoglobin and delivers it via the CD163 pathway to the reticuloendothelial system, where iron is reclaimed and recycled [10]. The system is efficient under normal conditions.
The problem arises when haptoglobin stores are repeatedly overwhelmed. When free hemoglobin exceeds the binding capacity of available haptoglobin, excess hemoglobin circulates freely and reaches the glomerulus, where it can be excreted as hemoglobinuria — carrying iron with it permanently. As discussed in the Journal of Applied Physiology study of running versus cycling hemolysis, daily or twice-daily hemolytic episodes during intensive training may produce cumulative iron losses that progressively erode stores, particularly in high-mileage runners [3]. Telford’s study also notes that the suggestion of footstrike trauma being associated with iron deficiency in runners is consistent with evidence that athletes in foot-impact sports show lower iron stores than cyclists, even after correction for body size and gender [3].
Thus, in some patients, hemolysis may indeed contribute to anemia. However, hemolysis alone is rarely sufficient to cause clinically significant anemia. Rather, it represents a cumulative effect, and other underlying causes should be considered and excluded as the primary drivers of anemia.
From a clinical perspective, it is also important to recognize that exercise-related hemolysis itself is not something that typically requires treatment, nor is it a reason to avoid physical activity. The primary focus should be on identifying and managing the underlying cause of anemia. In this context, hemolysis in athletes is often more of a nuance than a clinically actionable problem.
Summary
Haptoglobin is a useful laboratory marker of intravascular hemolysis, but in athletes—particularly endurance athletes—its interpretation requires careful clinical context. Reduced levels are a well-documented physiological consequence of repetitive mechanical stress and exercise-induced hemolysis, rather than an automatic indicator of pathology.
In most cases, low haptoglobin in athletes is asymptomatic and does not carry meaningful clinical consequences. It does not impair performance, does not require treatment, and is not, in itself, a reason to modify training. For this reason, haptoglobin should not be used as a routine screening tool in athletic populations, and exercise alone is not an indication for testing.
The clinical value of haptoglobin lies instead in appropriate interpretation. When measured outside the expected exercise context, or when accompanied by anemia or other abnormal findings, it can provide an important clue in identifying underlying hemolytic processes. However, when seen in isolation—particularly in close temporal proximity to endurance exercise—it is most often a benign, context-dependent finding.
Ultimately, the key is not the number itself, but the context in which it appears. Distinguishing physiological adaptation from pathological hemolysis is essential to avoid both unnecessary concern and missed diagnoses. In athletes, haptoglobin is best understood not as a problem to be corrected, but as a signal to be interpreted correctly.
References
1 https://doi.org/10.17161/kjm.vol17.22146
2 https://doi.org/10.21037/atm.2019.05.41
3 https://doi.org/10.1152/japplphysiol.00631.2001
4 https://pmc.ncbi.nlm.nih.gov/articles/PMC3417738/
7 https://pmc.ncbi.nlm.nih.gov/articles/PMC4706896/
